Page 14 - JCTR-10-6

324 Hanno et al.ǀ Journal of Clinical and Translational Research 2024; 10(6): 317-324
pylori: A systematic review and meta-analysis in triple therapy for Helicobacter pylori eradication: A
world health organization regions. Gastroenterology meta-analysis of randomized clinical trials. Biomed Res
2018;155:1372-82. Int 2019;2019:9781212.
doi: 10.1053/j.gastro.2018.07.007 doi: 10.1155/2019/9781212
[36] Villoria A, Garcia P, Calvet X, Gisbert JP, Vergara M. [39] Mahrous NL, Nasrelden E, Hassan M, Aboelmagd M.
Meta-analysis: High-dose proton pump inhibitors vs. Efficacy of Vonoprazan-based triple therapy for cure
standard dose in triple therapy for Helicobacter pylori of H. Pylori infection among patients attending GIT
eradication. Aliment Pharmacol Ther 2008;28:868-77. outpatient clinic at Suez Canal university hospital.
doi: 10.1111/j.1365-2036.2008.03807.x Microbes Infect Dis 2023;4:506-13.
[37] Mégraud F, Graham DY, Howden CW, Trevino E, doi: 10.21608/mid.2023.191490.1459
Weissfeld A, Hunt B, et al. Rates of antimicrobial [40] Furuta T, Yamade M, Kagami T, Uotani T, Suzuki T,
resistance in Helicobacter pylori isolates from Higuchi T, et al. Dual therapy with vonoprazan
clinical trial patients across the US and Europe. Am J and amoxicillin is as effective as triple therapy
Gastroenterol 2023;118:269-75. with Vonoprazan, amoxicillin and clarithromycin
doi: 10.14309/ajg.0000000000002045 for eradication of Helicobacter pylori. Digestion
[38] Lyu QJ, Pu QH, Zhong XF, Zhang J. Efficacy and safety 2020;101:743-51.
of vonoprazan-based versus proton pump inhibitor-based doi: 10.1159/000502287

Publisher’s note
AccScience Publishing remains neutral with regard to
jurisdictional claims in published maps and institutional
affiliations.

DOI: http://doi.org/10.36922/jctr.24.00043